Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe.
Our customers include physicians, optometrists, hospitals, surgery centers, clinics, long-term care, wholesalers, group purchasing organizations, retail pharmacies, and other pharmaceutical companies.
Akorn is committed to serving our customers by providing an extensive line of affordable, safe and efficacious pharmaceuticals the following markets:
- Ophthalmologic Pharmaceuticals: Solutions, Ointments, Gels, and Injectables
The Company’s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting.
We also sell therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, and preservative-free lubricating ointments.
- Specialty Therapeutics and Injectable Pharmaceuticals: Liquid and Lyophilized
The Company's Specialty Therapeutics and Injectable segment markets hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia; and other pharmaceutical products. This segment markets products to hospitals through the wholesale distribution channel.
- Contract Manufacturing
Our Contract Service segment manufactures aseptic filled and terminally sterilized ophthalmic and injectable pharmaceutical products from our facilities in Somerset, NJ and Decatur, IL for third party pharmaceutical customers.
Akorn was founded in 1971 and is headquartered in Lake Forest, Illinois.
| || |
| || || |
Longer Term Weekly
Point & Figure Chart
|INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS |
"We expect to add other vaccines produced by third party biologics manufacturers in the future..."
(an excerpt from recent filing).
FDA approval website